ASSESSING THE CLINICAL BENEFIT OF NMP22 IN THE SURVEIL LANCE OF PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER AND NEGATIVE CYTOLOGY A DECISION CURVE ANAL YSIS

被引：0
|
作者：
Shariat, Shahrokh F. [1 ]
Meryn, Siegfried [2 ]
Lee, Richard [1 ]
Marberger, Michael J. [2 ]
Scherr, Douglas S. [1 ]
Savage, Caroline [3 ]
Karakiewicz, Pierre I. [4 ]
Vickers, Andrew J.
机构：
[1] Weill Cornell Med Sch, New York, NY USA
[2] Med Univ Vienna, Vienna, Austria
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[4] Univ Montreal, Montreal, PQ, Canada
来源：
JOURNAL OF MENS HEALTH | 2010年 / 7卷 / 03期
关键词：
D O I：
10.1016/j.jomh.2010.09.192
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
191
引用
收藏
页码：341 / 341
页数：1
相关论文
共 12 条
  • [1] Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial
    Barbieri, Christopher E.
    Cha, Eugene K.
    Chromecki, Thomas F.
    Dunning, Allison
    Lotan, Yair
    Svatek, Robert S.
    Scherr, Douglas S.
    Karakiewicz, Pierre I.
    Sun, Maxine
    Mazumdar, Madhu
    Shariat, Shahrokh F.
    BJU INTERNATIONAL, 2012, 109 (05) : 685 - 690
  • [2] LONG TERM OUTCOME OF PATIENTS FOLLOWED FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMI-BC) PRESENTING WITH POSITIVE NMP22 AND NEGATIVE CYTOLOGY AND CYSTOSCOPY
    Serretta, Vincenzo
    Scuto, Fabio
    Ruggirello, Antonina
    Passalacqua, Dario
    Allegro, Rosalinda
    Melloni, Darvinio
    JOURNAL OF UROLOGY, 2010, 183 (04): : E455 - E455
  • [3] Assessing the Clinical Benefit of Nuclear Matrix Protein 22 in the Surveillance of Patients With Nonmuscle-Invasive Bladder Cancer and Negative Cytology
    Shariat, Shahrokh F.
    Savage, Caroline
    Chromecki, Thomas F.
    Sun, Maxine
    Scherr, Douglas S.
    Lee, Richard K.
    Lughezzani, Giovanni
    Remzi, Mesut
    Marberger, Michael J.
    Karakiewicz, Pierre I.
    Vickers, Andrew J.
    CANCER, 2011, 117 (13) : 2892 - 2897
  • [4] NMP22: Does it have a predictive potential for recurrence and progression in non-muscle-invasive bladder cancer?
    Kassouf, Wassim
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2009, 3 (06): : 459 - 459
  • [5] POSITIVE NMP22 AND ABSENCE OF EVIDENT UROLOGICAL DISEASE IN PATIENTS FOLLOWED FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMI-BC). LONG TERM OUTCOME
    Serretta, V.
    Scuto, F.
    Ruggirello, A.
    Passalacqua, D.
    Allegro, R.
    Melloni, D.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 49 - 49
  • [6] Clinical Decision Making in Surveillance of Non-Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers
    Zuiverloon, Tahlita C. M.
    de Jong, Florus C.
    Theodorescu, Dan
    ONCOLOGY-NEW YORK, 2017, 31 (12): : 855 - 862
  • [7] Clinical significance of immediate urine cytology after transurethral resection of bladder tumor in patients with non-muscle invasive bladder cancer
    Shin, Yu Seob
    Kim, Sang Deuk
    Cha, Jai Seong
    Kim, Myung Ki
    Jeong, Young Beom
    Kim, Hyung Jin
    INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (06) : 439 - 443
  • [8] Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to Cytology
    Ecke, Thorsten H.
    Meisl, Christina J.
    Schlomm, Thorsten
    Rabien, Anja
    Labonte, Flora
    Rong, Dezhi
    Hofbauer, Sebastian
    Friedersdorff, Frank
    Sommerfeldt, Lilli
    Gagel, Nella
    Goessl, Andreas
    Barski, Dimitri
    Otto, Thomas
    Grunewald, Camilla M.
    Niegisch, Guenter
    Hennig, Martin J. P.
    Kramer, Mario W.
    Koch, Stefan
    Roggisch, Jenny
    Weiss, Sarah
    Waldner, Michael
    Graff, Johannes
    Veltrup, Elke
    Linden, Friederike
    Hake, Roland
    Eidt, Sebastian
    Wirtz, Ralph M.
    Klatte, Tobias
    UROLOGY, 2025, 197 : 119 - 125
  • [9] Bacillus Calmette-Guerin may have clinical benefit for glandular or squamous differentiation in non-muscle invasive bladder cancer patients: retrospective multicenter study
    Yorozuya, Wakako
    Nishiyama, Naotaka
    Shindo, Tetsuya
    Kyoda, Yuki
    Itoh, Naoki
    Sugita, Shintaro
    Hasegawa, Tadashi
    Masumori, Naoya
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (07) : 661 - 666
  • [10] BACILLUS CALMETTE-GUERIN MAY HAVE CLINICAL BENEFIT FOR GLANDULAR OR SQUAMOUS DIFFERENTIATION IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS: RETROSPECTIVE MULTICENTER STUDY.
    Yorozuya, Wakako
    Nishiyama, Naotaka
    Shindo, Tetsuya
    Itoh, Naoki
    Hasegawa, Tadashi
    Masumori, Naoya
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1120 - E1121
12